Search

Showing total 6 results
Start Over Topic anatomy Journal urology times
6 results

1. SURGICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA: WHAT DEFINES A GOLD STANDARD?

Subjects
PROSTATECTOMY, TRANSURETHRAL prostatectomy, BENIGN prostatic hyperplasia, URINARY organs, PROSTATE-specific antigen, ANATOMY
Abstract

Information about the convention of an expert panel to examine gold standard criteria for the treatment of male benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) is presented. Topics include the use of transurethral resection of the prostate (TURP) prevailed the BPH landscape, the evolution of laser surgery for BPH and measure of efficacy in clinical trial. The convention featured Dr. Kevin McVary, Dr. Alexander Bachmann and Dr. Kevin C. Zorn.

Published
2015

2. Bladder cancer study identifies therapeutic targets.

Author

Goodman, Alice

Subjects
BLADDER, BLADDER tumors, GENES, GENOMES, GENETIC mutation, ONCOLOGY, PRESS, UROLOGY, TREATMENT effectiveness, INVESTIGATIONAL drugs, ANATOMY, TUMOR treatment
Abstract

The article reports on a bladder cancer study which attempts to identify therapeutic targets. Lead by Dr. Jonathan Rosenberg, the Cancer Genome Atlas (TCGA) project at the Genitourinary Cancers Symposium in San Francisco, California aims to identify therapies targeted to actionable mutations and provide clinical benefits in appropriately selected subsets of patients.

Published
2014

3. PDE-5 inhibitors found safe, efficacious for LUTS.

Author

Binder, Stefanie Petrou

Subjects
PHOSPHODIESTERASE inhibitors, URINARY organs, AGE distribution, URINARY tract infections, BODY mass index, ANATOMY, THERAPEUTICS
Abstract

The article presents a meta-analysis on the efficacy of Phosphodiesterase type-5 inhibitors (PDE-5). The analysis reveals that PDE-5 are effective and safe, alone or combined with alpha-blockers, against lower urinary tract symptoms (LUTS) which is secondary to benign prostatic hyperplasia (BPH). It shows that the two-drug combination improves the rate of maximum flow equated to alpha-blockers.

Published
2012

4. IN THE PUBLIC Eye.

Subjects
BCG vaccines, IMPOTENCE, MEMORY, ROSACEA, TESTOSTERONE, URINARY organs, ANATOMY
Abstract

Reprint of articles including "Men remember first car, but not last doctor's appointment' which appeared in periodical "Today Show Health", "BCG shortage frustrates patients, docs" which appeared in "The Wall Street Journal" and "CV autonomic neuropathy linked with erectile dysfunction, LUTS" which appeared in "Healthday News" are presented.

Published
2015

5. Combination therapy for male LUTS may be preferred over monotherapy.

Subjects
URINARY organ diseases, URINARY organs, DRUG therapy, COMBINATION drug therapy, ANATOMY, THERAPEUTICS
Abstract

The article presents a study that investigates the effectiveness of combination therapy in treating lower urinary tract symptoms (LUTS).

Published
2013

6. Anatomic features predict post-RP continence.

Author

Krader, Cheryl Guttman

Subjects
URINARY organs, MAGNETIC resonance imaging, POSTOPERATIVE care, PROSTATECTOMY, URINATION, ANATOMY
Abstract

The article reports on the effectiveness of anatomic features in preoperative magnetic resonance imaging (MRI) in predicting continence after radical prostatectomy (RP) in patients with prostate cancer. It notes the findings of the researchers from Memorial Sloan-Keteritn Cancer in New York, which reveals that men who underwent prostatectomy with preoperative MRI have found with preoperative incontinence (PI). The researchers have explored the other uses of MRI to further understand PI.

Published
2011